• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MICRO THERAPEUTICS, INC. DBA EV3 PIPELINE; INTRACRANIAL ANEURYSM FLOW DIVERTER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MICRO THERAPEUTICS, INC. DBA EV3 PIPELINE; INTRACRANIAL ANEURYSM FLOW DIVERTER Back to Search Results
Model Number NV UNK PIPELINE
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Aneurysm (1708)
Event Date 04/01/2020
Event Type  Injury  
Manufacturer Narrative
Reported patient age ((b)(6)) is representative of the mean age of all patient included in the study.Reported patient sex (female) is representative of the majority of patients included in the study.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Park, k.Y., yeon, j.Y., kim, b.M., jeon, p., kim, j.-h., jang, c.K., kim, d.J., lee, j.W., kim, y.B., chung, j., song, d.H., park, h.G., <(>&<)> park, j.S.(2020).Efficacy and safety of flow-diverter therapy for recurrent aneurysms after stent-assisted coiling.Ajnr.American journal of neuroradiology, 41(4), 663¿668.Https://doi.Org/10.3174/ajnr.A6476.Abstract background and purpose: flow-diverter treatment for previously stented aneurysms has been reported to be less effective and prone to complications.In this study, we evaluated the effectiveness and safety of flow diverters for recurrent aneurysms after stent-assisted coiling.Materials and methods: patients who underwent flow-diverter placement for recurrent aneurysms after stent-assisted coiling between march 2015 and march 2019 were recruited.Clinical and radiographic characteristics and clinical and angiographic outcomes were retrospectively evaluated.Results: among 133 patients who underwent flow-diverter insertion, 17 (male/female ratio = 5:12; mean age, 53.8 years) were treated for recurrent aneurysms after stent placement with (n ¼ 16) or without (n ¼ 1) coiling.Eight patients initially presented with subarachnoid hemorrhage; 7, with headache; and 2, with visual field defects.Angiographic morphology included large/giant saccular in 12 patients, dissecting in 2, fusiform in 1, traumatic pseudoaneurysm in 1, and ruptured blood blister-like aneurysm in 1.The duration between the first treatment and flow-diverter placement ranged from 2 weeks to 15 months (median, 6 months).Flow-diverter placement was successful in all cases without any complications.All patients had favorable outcomes (mrs, 0¿2), without any newly appearing symptoms.Aneurysms were followed up with conventional angiography at least once in 6¿18 months.Sixteen aneurysms showed complete occlusion, and 1 aneurysm was enlarged.Conclusions: results from this case series investigating flow-diverter placement for recurrent aneurysms after stent-assisted coiling suggested that the procedure is safe and effective.Further study in a larger population may be warranted.Medtronic review of the literature article found that both pipeline classic and pipeline flex devices were used and it was not specified in which cases what device was used.All procedures were considered successful.All patients had favorable outcomes and there were no new neurological deficits.In only one case, the middle cerebral artery (mca) dissecting aneurysm was observed to be enlarged during follow-up.The patient underwent a third procedure to place an additional flow-diverter.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PIPELINE
Type of Device
INTRACRANIAL ANEURYSM FLOW DIVERTER
Manufacturer (Section D)
MICRO THERAPEUTICS, INC. DBA EV3
9775 toledo way
irvine CA 92618
Manufacturer (Section G)
MICRO THERAPEUTICS, INC. DBA EV3
9775 toledo way
irvine CA 92618
Manufacturer Contact
glen belmer
9775 toledo way
irvine, CA 92618
6122713209
MDR Report Key13558954
MDR Text Key286141049
Report Number2029214-2022-00236
Device Sequence Number1
Product Code OUT
Combination Product (y/n)N
Reporter Country CodeKS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature,Health Professional
Reporter Occupation Physician
Type of Report Initial
Report Date 02/18/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/18/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberNV UNK PIPELINE
Device Catalogue NumberNV UNK PIPELINE
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/28/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age53 YR
Patient SexFemale
-
-